- Home
- CTOR
CTOR
CITIUS ONCOLOGY INC
as 01-17-2025 4:00pm EST
Stocks
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 89.9M | IPO Year: | N/A |
| Target Price: | $4.50 | AVG Volume (30 days): | 171.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.85 - $49.00 | Next Earning Date: | 02-21-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest CITIUS ONCOLOGY INC News
CTOR Breaking Stock News: Dive into CTOR Ticker-Specific Updates for Smart Investing
PR Newswire
11 days ago
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
TipRanks
11 days ago
Citius Oncology to explore strategic alternatives
PR Newswire
12 days ago
Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives
TipRanks
18 days ago
Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital
PR Newswire
22 days ago
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
PR Newswire
22 days ago
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
Simply Wall St.
2 months ago
Citius Oncology, Inc.'s (NASDAQ:CTOR) Path To Profitability
PR Newswire
4 months ago
Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Compare CTOR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CTOR CITIUS ONCOLOGY INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.